Radaic et al., 2020 - Google Patents
Bacterial anti-microbial peptides and nano-sized drug delivery systems: The state of the art toward improved bacteriocinsRadaic et al., 2020
- Document ID
- 12752900919974780767
- Author
- Radaic A
- de Jesus M
- Kapila Y
- Publication year
- Publication venue
- Journal of Controlled Release
External Links
Snippet
Antimicrobial peptides (AMP) are molecules consisting of 12–100 amino acids synthesized by certain microbes and released extracellularly to inhibit the growth of other microbes. Among the AMP molecules, bacteriocins are produced by both gram-positive and gram …
- 108010062877 Bacteriocins 0 title abstract description 115
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Radaic et al. | Bacterial anti-microbial peptides and nano-sized drug delivery systems: The state of the art toward improved bacteriocins | |
Kumariya et al. | Bacteriocins: Classification, synthesis, mechanism of action and resistance development in food spoilage causing bacteria | |
Dicks et al. | A review: the fate of bacteriocins in the human gastro-intestinal tract: do they cross the gut–blood barrier? | |
Tiwari et al. | Probiotics at war against viruses: what is missing from the picture? | |
Rios et al. | Alternatives to overcoming bacterial resistances: State-of-the-art | |
Carmona-Ribeiro et al. | Novel formulations for antimicrobial peptides | |
Arthur et al. | On bacteriocin delivery systems and potential applications | |
Hassan et al. | Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance | |
Subramaniam et al. | Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections | |
Sidhu et al. | Bacteriocin-nanoconjugates as emerging compounds for enhancing antimicrobial activity of bacteriocins | |
Bi et al. | Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide | |
Hong et al. | PEGylated self-assembled nano-bacitracin A: probing the antibacterial mechanism and real-time tracing of target delivery in vivo | |
Niaz et al. | Antimicrobial and antibiofilm potential of bacteriocin loaded nano-vesicles functionalized with rhamnolipids against foodborne pathogens | |
Choi et al. | Drug delivery strategies for antibiofilm therapy | |
Dicks et al. | Medical and personal care applications of bacteriocins produced by lactic acid bacteria | |
Faya et al. | Conjugates and nano-delivery of antimicrobial peptides for enhancing therapeutic activity | |
Yan et al. | Formulation strategies for bacteriophages to target intracellular bacterial pathogens | |
Sulthana et al. | Bacteriocin nanoconjugates: Boon to medical and food industry | |
Martin et al. | The expanding role of lipid II as a target for lantibiotics | |
Cornut et al. | Antineoplastic properties of bacteriocins: revisiting potential active agents | |
AU2006231494A1 (en) | Use of RIP in treating Staphylococcus aureus infections | |
Azmi et al. | Towards the development of synthetic antibiotics: Designs inspired by natural antimicrobial peptides | |
El-Fakharany | Nanoformulation approach for improved stability and efficiency of lactoperoxidase | |
Daba et al. | Ribosomally synthesized bacteriocins of lactic acid bacteria: Simplicity yet having wide potentials–A review | |
Pervin et al. | Synergistic therapeutic actions of antimicrobial peptides to treat multidrug-resistant bacterial infection |